Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Changsu Han

Showing results (141-150 of 276) with videos related to

Pageof 28
Sort By:
Journal of Psychiatric Research|November 5, 2016
Modafinil for the treatment of attention-deficit/hyperactivity disorder: A meta-analysisSheng-Min Wang, Changsu Han, Soo-Jung Lee, et al.
Chonnam Medical Journal|June 2, 2018
Addressing the Side Effects of Contemporary Antidepressant Drugs: A Comprehensive ReviewSheng-Min Wang, Changsu Han, Won-Myoung Bahk, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|April 22, 2009
History of early abuse as a predictor of treatment response in patients with fibromyalgia: a post-hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled releaseChi-Un Pae, Prakash S Masand, David M Marks, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|October 24, 2007
Fluoxetine versus sertraline in the treatment of patients with undifferentiated somatoform disorder: a randomized, open-label, 12-week, parallel-group trialChangsu Han, Chi-Un Pae, Bun Hee Lee, et al.
Chonnam Medical Journal|February 12, 2019
Erratum: Correction of Acknowledgements Second Generation Antipsychotics in the Treatment of Major Depressive Disorder: An UpdateSheng-Min Wang, Changsu Han, Soo-Jung Lee, et al.
Expert Review of Neurotherapeutics|February 4, 2015
Curcumin as a putative antidepressantHo-Jun Seo, Sheng-Min Wang, Changsu Han, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|July 23, 2021
Changes in Brain Electrical Activity According to Post-traumatic Stress Symptoms in Survivors of the Sewol Ferry Disaster: A 1-year Longitudinal StudySehee Jin, Cheolmin Shin, Changsu Han, et al.
Psychosomatics|December 10, 2009
Psychometric properties of the Patient Health Questionnaire-15 (PHQ-15) for measuring the somatic symptoms of psychiatric outpatientsChangsu Han, Chi-Un Pae, Ashwin A Patkar, et al.
Expert Opinion on Drug Safety|November 6, 2008
Paroxetine: safety and tolerability issuesDavid M Marks, Min-Hyeon Park, Byung-Joo Ham, et al.
Neuropsychiatric Disease and Treatment|December 14, 2020
Definition and Identification of Patients with Treatment-Resistant Depression in Real-World Clinical Practice Settings Across AsiaChangsu Han, Gang Wang, Sandra Chan, et al.
Pageof 28

Showing results (141-150 of 276) with videos related to

Sort By:
Pageof 28
Journal of Psychiatric Research|November 5, 2016
Modafinil for the treatment of attention-deficit/hyperactivity disorder: A meta-analysisSheng-Min Wang, Changsu Han, Soo-Jung Lee, et al.
Chonnam Medical Journal|June 2, 2018
Addressing the Side Effects of Contemporary Antidepressant Drugs: A Comprehensive ReviewSheng-Min Wang, Changsu Han, Won-Myoung Bahk, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|April 22, 2009
History of early abuse as a predictor of treatment response in patients with fibromyalgia: a post-hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled releaseChi-Un Pae, Prakash S Masand, David M Marks, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|October 24, 2007
Fluoxetine versus sertraline in the treatment of patients with undifferentiated somatoform disorder: a randomized, open-label, 12-week, parallel-group trialChangsu Han, Chi-Un Pae, Bun Hee Lee, et al.
Chonnam Medical Journal|February 12, 2019
Erratum: Correction of Acknowledgements Second Generation Antipsychotics in the Treatment of Major Depressive Disorder: An UpdateSheng-Min Wang, Changsu Han, Soo-Jung Lee, et al.
Expert Review of Neurotherapeutics|February 4, 2015
Curcumin as a putative antidepressantHo-Jun Seo, Sheng-Min Wang, Changsu Han, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|July 23, 2021
Changes in Brain Electrical Activity According to Post-traumatic Stress Symptoms in Survivors of the Sewol Ferry Disaster: A 1-year Longitudinal StudySehee Jin, Cheolmin Shin, Changsu Han, et al.
Psychosomatics|December 10, 2009
Psychometric properties of the Patient Health Questionnaire-15 (PHQ-15) for measuring the somatic symptoms of psychiatric outpatientsChangsu Han, Chi-Un Pae, Ashwin A Patkar, et al.
Expert Opinion on Drug Safety|November 6, 2008
Paroxetine: safety and tolerability issuesDavid M Marks, Min-Hyeon Park, Byung-Joo Ham, et al.
Neuropsychiatric Disease and Treatment|December 14, 2020
Definition and Identification of Patients with Treatment-Resistant Depression in Real-World Clinical Practice Settings Across AsiaChangsu Han, Gang Wang, Sandra Chan, et al.
Pageof 28